Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Mansoura university, Mansoura, Dkahleya, Egypt
Division de Anestesia - Pontificia Universidad Catolica de Chile, Santiago, Region Metropolitana, Chile
GZA Sint Augustinus, Wilrijk, Antwerpen, Belgium
Gangnam Severance hospital, Seoul, Gangnam-gu, Korea, Republic of
General Hospital Zadar, Zadar, Croatia
Mansoura university, Mansoura, Dakahleya, Egypt
National Taiwan University Hospital, Taipei City, Taiwan
Department of Critical care medicine of West China Hospital, Chengdu, Sichuan, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.